About the Authors

Yumi Shirai

Affiliation Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan

Yuko Fujita

Affiliation Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan

Ryota Hashimoto

Affiliations Molecular Research Center for Children’s Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan, Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan

Kazutaka Ohi

Affiliation Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan

Hidenaga Yamamori

Affiliation Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan

Yuka Yasuda

Affiliation Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan

Tamaki Ishima

Affiliation Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan

Hiroyuki Suganuma

Affiliation Research & Development Division, Kagome Co. Ltd., Tochigi, Japan

Yusuke Ushida

Affiliation Research & Development Division, Kagome Co. Ltd., Tochigi, Japan

Masatoshi Takeda

Affiliation Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan

Kenji Hashimoto

hashimoto@faculty.chiba-u.jp

Affiliation Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan

Competing Interests

The authors have the following interests: Drs. H. Suganuma and Y. Ushida are employees of Kagome Co, Ltd., which provided SFN-rich supplement. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: KH. Performed the experiments: YS YF RH KO HY YY TI. Analyzed the data: YS RH KO. Contributed reagents/materials/analysis tools: KO HY YY HS YU MT. Wrote the paper: YS RH KO KH.